A phase 2 trial of Nivolumab in recurrent or metastatic platinum-refractory non-squamous cell carcinoma of the head and neck (UMIN-CTR) - Oct 2, 2026 - P2 | N=24 | Completed | Sponsor: Medical Oncology / Hematology, Department of Medicine Kobe University Hospital and Graduate School of Medicine | Phase classification: P=N/A ➔ P2
Phase classification • Head and Neck Cancer • Oncology • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • PD-L1
|